pk 11195 has been researched along with Phobic Disorders in 2 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auta, J | 1 |
| Romeo, E | 1 |
| Kozikowski, A | 1 |
| Ma, D | 1 |
| Costa, E | 1 |
| Guidotti, A | 1 |
| Johnson, MR | 1 |
| Marazziti, D | 1 |
| Brawman-Mintzer, O | 1 |
| Emmanuel, NP | 1 |
| Ware, MR | 1 |
| Morton, WA | 1 |
| Rossi, A | 1 |
| Cassano, GB | 1 |
| Lydiard, RB | 1 |
1 trial available for pk 11195 and Phobic Disorders
| Article | Year |
|---|---|
Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia.
Topics: Adult; Blood Platelets; Female; Humans; Isoquinolines; Male; Peripheral Nervous System; Phobic Disor | 1998 |
1 other study available for pk 11195 and Phobic Disorders
| Article | Year |
|---|---|
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.
Topics: Aggression; Allosteric Regulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; | 1993 |